Clinical Trials Directory

Trials / Completed

CompletedNCT01253122

Comparative Bioavailability in Healthy Elderly Volunteers

Comparative Bioavailability of TRx0037 and TRx0014 in Healthy Elderly Volunteers

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
24 (actual)
Sponsor
TauRx Therapeutics Ltd · Industry
Sex
All
Age
55 Years
Healthy volunteers
Accepted

Summary

A randomised four way crossover design in which each subject will receive two dose levels of TRx-0037 and two doses of TRx-0014 over approximately a four week period in randomised order.

Conditions

Interventions

TypeNameDescription
DRUGTRx0037

Timeline

Start date
2010-02-01
Primary completion
2010-04-01
Completion
2010-04-01
First posted
2010-12-03
Last updated
2010-12-03

Source: ClinicalTrials.gov record NCT01253122. Inclusion in this directory is not an endorsement.